| Nuclear Receptor Nr4a2 Promotes Alternative Polarization of Macrophages and Confers Protection in Sepsis*♦ S Mahajan, A Saini, V Chandra, R Nanduri, R Kalra, E Bhagyaraj, ... Journal of Biological Chemistry 290 (30), 18304-18314, 2015 | 73 | 2015 |
| The active form of vitamin D transcriptionally represses Smad7 signaling and activates extracellular signal-regulated kinase (ERK) to inhibit the differentiation of a … R Nanduri, S Mahajan, E Bhagyaraj, K Sethi, R Kalra, V Chandra, ... Journal of Biological Chemistry 290 (19), 12222-12236, 2015 | 42 | 2015 |
| Vitamin D3-VDR-PTPN6 axis mediated autophagy contributes to the inhibition of macrophage foam cell formation S Kumar, R Nanduri, E Bhagyaraj, R Kalra, N Ahuja, AP Chacko, D Tiwari, ... Autophagy 17 (9), 2273-2289, 2021 | 41 | 2021 |
| Human xenobiotic nuclear receptor PXR augments Mycobacterium tuberculosis survival E Bhagyaraj, R Nanduri, A Saini, HK Dkhar, N Ahuja, V Chandra, ... The Journal of Immunology 197 (1), 244-255, 2016 | 24 | 2016 |
| AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment R Kalra, E Bhagyaraj, D Tiwari, R Nanduri, AP Chacko, M Jain, ... Oncogenesis 7 (5), 43, 2018 | 21 | 2018 |
| A human xenobiotic nuclear receptor contributes to nonresponsiveness of Mycobacterium tuberculosis to the antituberculosis drug rifampicin E Bhagyaraj, D Tiwari, N Ahuja, R Nanduri, A Saini, R Kalra, S Kumar, ... Journal of Biological Chemistry 293 (10), 3747-3757, 2018 | 19 | 2018 |
| An Accord of Nuclear Receptor Expression in M. tuberculosis Infected Macrophages and Dendritic Cells A Saini, S Mahajan, N Ahuja, E Bhagyaraj, R Kalra, AK Janmeja, P Gupta Scientific reports 8 (1), 2296, 2018 | 18 | 2018 |
| AutophagySMDB: a curated database of small molecules that modulate protein targets regulating autophagy R Nanduri, R Kalra, E Bhagyaraj, AP Chacko, N Ahuja, D Tiwari, S Kumar, ... Autophagy 15 (7), 1280-1295, 2019 | 16 | 2019 |
| Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer NB Punturi, S Seker, V Devarakonda, A Mazumder, R Kalra, CH Chen, ... Nature communications 12 (1), 2940, 2021 | 15 | 2021 |
| Poziotinib inhibits HER2-mutant–driven therapeutic resistance and multiorgan metastasis in breast cancer R Kalra, CH Chen, J Wang, AB Salam, LE Dobrolecki, A Lewis, C Sallas, ... Cancer Research 82 (16), 2928-2939, 2022 | 9 | 2022 |
| Frienemies of infection: A chronic case of host nuclear receptors acting as cohorts or combatants of infection S Mahajan, A Saini, R Kalra, P Gupta Critical reviews in microbiology 42 (4), 526-534, 2016 | 8 | 2016 |
| Nuclear receptor Nr1d1 alleviates asthma by abating GATA3 gene expression and Th2 cell differentiation D Tiwari, N Ahuja, S Kumar, R Kalra, R Nanduri, S Gupta, AK Khare, ... Cellular and Molecular Life Sciences 79 (6), 308, 2022 | 7 | 2022 |
| Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy R Kalra, D Tiwari, HK Dkhar, E Bhagyaraj, R Kumar, A Bhardwaj, P Gupta International reviews of immunology 42 (1), 43-70, 2023 | 4 | 2023 |
| An accord of nuclear receptor expression in CD4+ T Cells in Rheumatoid arthritis A Saini, S Mahajan, E Bhagyaraj, R Kalra, R Nanduri, R Gupta, N Khatri, ... ImmunoHorizons 3 (8), 402-411, 2019 | 4 | 2019 |
| Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma C Yan, MA Richard, CJ Gibson, J He, A Bosworth, DK Crossman, P Singh, ... Journal of Clinical Oncology, JCO. 23.02547, 2024 | | 2024 |
| The uncharted role of HER2 mutant alleles in breast cancer R Kalra, B Lim, MJ Ellis, SM Kavuri Oncotarget 14, 904, 2023 | | 2023 |
| Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+ HER2 mutant breast cancer SM Kavuri, R Kalra, CH Chen, J Wang, A Bin Salam, L Dobrolecki, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P2-13-24: Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+ HER2 mutant breast cancer SM Kavuri, R Kalra, CH Chen, J Wang, AB Salam, L Dobrolecki, A Lewis, ... Cancer Research 82 (4_Supplement), P2-13-24-P2-13-24, 2022 | | 2022 |
| Abstract PD8-05: Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer S Haricharan, N Punturi, S Seker, V Devarakonda, R Kalra, CH Chen, ... Cancer Research 81 (4_Supplement), PD8-05-PD8-05, 2021 | | 2021 |
